ACT vs UBSI

ACT's Piotroski F-Score of 4/9 indicates weak financial health, signaling potential operational inefficiencies despite strong profitability. The absence of an Altman Z-Score raises concern about default risk, especially given the sector's average debt levels. While the company trades below its Graham Number ($61.88) and intrinsic value ($133.34), its current price of $40.49 reflects a significant discount, likely due to low growth and weak financial stability signals. Insider selling activity over the past six months adds bearish sentiment, and analyst consensus remains at 'hold' with limited upside. The stock's strong historical earnings surprises and high margins are offset by stagnant revenue growth and elevated peer P/E multiples.

UBSI presents a compelling value opportunity, trading significantly below both its Graham Number ($53.83) and Intrinsic Value ($96.47). While the Piotroski F-Score of 4/9 indicates stable but not exceptional financial health, the company exhibits powerful growth metrics with YoY revenue and earnings growth exceeding 29%. Despite a very bearish technical trend (10/100), the fundamental disconnect between the current price ($43.61) and its valuation benchmarks suggests a strong margin of safety.